The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO Sarcoma & GIST 2022 | The survivorship of patients with sarcoma
Piotr Rutkowski, MD, PhD, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland, talks on the survivorship of patients with sarcoma. Dr. Rutkowski explains how it is essential for a patient to be treated in an experienced sarcoma center to increase quality of life, as well as the chances of cure. This interview took place during the European Society for Medical Oncology (ESMO) Sarcoma & GIST Symposium.
